Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
372 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00445861 | Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 27 | Swiss Cancer InstituteOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00217711 | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 23 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 |
| clinicaltrials |
| NCT00003230 | Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | completed | Phase 1 / Phase 2 | 33 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00749346 | NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 42 | NovoCure Ltd.INDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01148628 | Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 54 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01155505 | Lenalidomide and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 28 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01159418 | LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 36 | Southern Europe New Drug OrganizationOTHER | 1 | Sep 13, 2011 | clinicaltrials |
| NCT00392470 | Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer | unknown | Phase 1 | 20 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | May 25, 2011 | clinicaltrials |
| NCT00265057 | Study of ADH-1 Given Intravenously to Patients With Solid Tumors | completed | Phase 1 / Phase 2 | — | Adherex Technologies, Inc.INDUSTRY | 2 | Dec 28, 2010 | clinicaltrials |
| NCT00357617 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 24 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00478374 | Sorafenib With TACE to Treat Hepatocellular Carcinoma(S-TACE) | completed | Phase 1 | 21 | University of BernOTHER | 1 | Nov 2, 2010 | clinicaltrials |
| NCT01220284 | Satraplatin and Vinorelbine in Advanced Solid Tumors | unknown | Phase 1 | 27 | Southern Europe New Drug OrganizationOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00681967 | Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer(IRESSA&H&N) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00572637 | Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas | completed | Phase 1 | 55 | Ethical Oncology ScienceINDUSTRY | 2 | May 20, 2010 | clinicaltrials |
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma(GEMOXEL) | completed | Phase 1 / Phase 2 | 46 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00886353 | Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) | completed | Phase 1 | 22 | Apeiron BiologicsINDUSTRY | 1 | Dec 31, 2009 | clinicaltrials |
| NCT00116597 | Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma | completed | Phase 1 / Phase 2 | 15 | University Hospital, Basel, SwitzerlandOTHER | 1 | Dec 2, 2009 | clinicaltrials |
| NCT00578916 | Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects | completed | Phase 1 | 17 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 31, 2008 | clinicaltrials |
| NCT00306566 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients | completed | Phase 1 / Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 20, 2007 | clinicaltrials |
| NCT00160992 | Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients | suspended | Phase 1 | 6 | University of Lausanne HospitalsOTHER | 1 | Sep 12, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials